Efavirenz Emtricitabine And Tenofovir Tablets IP

Name: Efavirenz Emtricitabine And Tenofovir Tablets IP
Brand: NEETCO BIOPHARMA
Price: 1500 INR
Availability: InStock

Price 1500 INR/ Bottle

Get a Price/Quote

MOQ : 1 Bottle

Efavirenz Emtricitabine And Tenofovir Tablets IP Specification

Medicine Type
Allopathic

Pacakaging (Quantity Per Box)
30 tablets per box

Assay
98.0% - 102.0%

Grade
Pharmaceutical Grade

Storage
Store below 30C, protect from light and moisture

Dosage
600 mg/200 mg/300 mg

Appearance
Film-coated tablet

Usage
Antiviral (HIV treatment)

Molecular Formula
Efavirenz: C14H9ClF3NO2, Emtricitabine: C8H10FN3O3S, Tenofovir Disoproxil Fumarate: C19H30N5O10P

Expiration Date
36 months from manufacture

CAS No
154598-52-4, 143491-57-0, 147127-20-6

Origin of Medicine
India

Indication
Used in the treatment of HIV-1 infection

Dosage Form
Tablet

Salt Composition
Efavirenz 600 mg + Emtricitabine 200 mg + Tenofovir Disoproxil Fumarate 300 mg

About Efavirenz Emtricitabine And Tenofovir Tablets IP

Last Chance to get the Latest Efavirenz Emtricitabine And Tenofovir Tablets IP, a top-notch, first-class solution for HIV-1 treatment. Popular among healthcare professionals, this allopathic medicine offers a sublime blend of Efavirenz (600 mg), Emtricitabine (200 mg), and Tenofovir Disoproxil Fumarate (300 mg) in each film-coated, yellow tablet. Packaged in HDPE bottles or Alu-Alu Blister packs, these pharmaceutical-grade tablets boast an assay of 98.0% - 102.0% and a shelf life of 36 months. Manufactured in a WHO GMP and ISO certified facility, it is available for export from India. Prescription is required as per Schedule H regulations.

Efavirenz Emtricitabine And Tenofovir Tablets IP: Usage and Application

Administered orally, Efavirenz Emtricitabine And Tenofovir Tablets IP are indicated for the management of HIV-1 infection. Designed for daily use, this top-tier antiviral therapy ensures competitive effectiveness with a well-balanced salt composition. Distinguished by a first-rate safety profile and ISO-certified manufacturing, these tablets provide a reliable solution for healthcare providers and patients alike, conforming to global regulatory standards and offering the advantage of long shelf-life.

Packaging, Market Availability, and Logistics for Efavirenz Emtricitabine And Tenofovir

Supplied in HDPE bottles or Alu-Alu Blister packs with 30 tablets per box, our proposal amount matches your precise requirements. Order completion is supported by efficient logistics, ensuring tablets are shipped promptly to various destinations. Efavirenz Emtricitabine And Tenofovir Tablets IP are widely available in the main domestic market across India, with robust supply ability to fulfill distributor and exporter demands consistently.

FAQ's of Efavirenz Emtricitabine And Tenofovir Tablets IP:

Q: How should Efavirenz Emtricitabine And Tenofovir Tablets IP be administered?

A: The tablets are taken orally as prescribed by your healthcare provider, typically once daily, for the treatment of HIV-1 infection.

Q: What packaging options are available for these tablets?

A: Efavirenz Emtricitabine And Tenofovir Tablets IP are supplied in HDPE bottles or Alu-Alu Blister packs, with 30 tablets per box to ensure secure and effective distribution.

Q: When do these tablets expire and how should they be stored?

A: The tablets have a shelf life of 36 months from the manufacturing date. They should be stored below 30C, protected from light and moisture.

Q: Where is Efavirenz Emtricitabine And Tenofovir Tablets IP manufactured and exported?

A: These tablets are manufactured in India in facilities certified by WHO GMP and ISO, and are available for export to various countries, subject to regulatory approval.

Q: What are the competitive advantages of Efavirenz Emtricitabine And Tenofovir Tablets IP?

A: Competitive advantages include pharmaceutical grade quality, ISO and WHO GMP certified production, precise assay range, sublime safety profile, and convenient packaging, making them a preferred choice for HIV-1 treatment globally.

Q: What are the common side effects of using this medication?

A: Reported side effects include dizziness, headache, rash, insomnia, and nausea. Consult your healthcare provider if you experience any adverse reactions.

Tell us about your requirement